ArticleCancer research and treatment2026

Cost-Effectiveness Analysis of Daratumumab Monotherapy and Subsequent Therapies in Heavily Treated Relapsed/Refractory Multiple Myeloma: A Feasible Methodology using a Korean Nationwide Population Cohort.

Sung-Soo Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.